Advertisement
Screener

WEWARDS, INC. (WEWA) Research and Development Expense

2.8 / 5 stars · 68/120 Roast Me

WEWARDS, INC. Research and Development Expense

WEWARDS, INC. (WEWA) reported Research and Development Expense of $1.62 million for the 12-month period ending 2022-05-31, per its 10-K filed 2026-09-14.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:ResearchAndDevelopmentExpense · last filed 2026-09-14

  • WEWARDS, INC. research and development expense for the quarter ending 2022-05-31 was $0.00, a 100.00% decline year-over-year.
  • WEWARDS, INC. research and development expense for the quarter ending 2022-02-28 was $611.50K, a 81.45% increase year-over-year.
  • WEWARDS, INC. research and development expense for the quarter ending 2021-11-30 was $505.50K.
  • WEWARDS, INC. research and development expense for the quarter ending 2021-08-31 was $505.50K.
  • WEWARDS, INC. research and development expense for fiscal 2022 was $1.62M.
  • WEWARDS, INC. research and development expense for fiscal 2019 was $447.42K, a 78.87% decline from fiscal 2018.
  • WEWARDS, INC. research and development expense for fiscal 2018 was $2.12M, a 55.04% decline from fiscal 2017.
  • WEWARDS, INC. research and development expense for fiscal 2017 was $4.71M.
Period endResearch and Development Expense 3 monthResearch and Development Expense 6 monthResearch and Development Expense 9 monthResearch and Development Expense 12 month
2022-05-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-14
$611.50K
derived: sum of 2 quarters · filed 2026-09-14
$1.12M
derived: sum of 3 quarters · filed 2026-09-14
$1.62M
10-K · filed 2026-09-14
2022-02-28$611.50K
10-Q · filed 2023-04-14
$1.12M
derived: sum of 2 quarters · filed 2023-04-14
$1.62M
10-Q · filed 2023-04-14
$2.13M
derived: sum of 4 quarters · filed 2023-04-14
2021-11-30$505.50K
10-Q · filed 2023-01-13
$1.01M
10-Q · filed 2023-01-13
$1.52M
derived: sum of 3 quarters · filed 2023-04-14
$1.85M
derived: sum of 4 quarters · filed 2023-04-14
2021-08-31$505.50K
10-Q · filed 2022-10-17
$1.01M
derived: sum of 2 quarters · filed 2023-04-14
$1.35M
derived: sum of 3 quarters · filed 2023-04-14
2021-05-31$505.50K
derived: 10-Q 12 month − 10-Q 9 month · filed 2023-04-14
$842.50K
derived: sum of 2 quarters · filed 2023-04-14
$842.50K
10-Q · filed 2023-04-14
2021-02-28$337.00K
10-Q · filed 2022-04-12
$337.00K
10-Q · filed 2022-04-12
2019-05-31$432.20K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-31
$432.20K
derived: sum of 2 quarters · filed 2020-08-31
$447.42K
derived: sum of 3 quarters · filed 2020-08-31
$447.42K
10-K · filed 2020-08-31
2019-02-28$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-04-12
$15.22K
derived: sum of 2 quarters · filed 2019-04-12
$15.22K
10-Q · filed 2019-04-12
2018-11-30$15.22K
10-Q · filed 2019-01-18
$15.22K
10-Q · filed 2019-01-18
2018-05-31-$314.97K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-23
$78.29K
derived: sum of 2 quarters · filed 2019-09-23
$1.09M
derived: sum of 3 quarters · filed 2019-09-23
$2.12M
10-K · filed 2019-09-23
2018-02-28$393.26K
10-Q · filed 2019-04-12
$1.40M
derived: sum of 2 quarters · filed 2019-04-12
$2.43M
10-Q · filed 2019-04-12
$3.04M
derived: sum of 4 quarters · filed 2019-04-12
2017-11-30$1.01M
10-Q · filed 2019-01-18
$2.04M
10-Q · filed 2019-01-18
$2.65M
derived: sum of 3 quarters · filed 2019-01-18
$4.58M
derived: sum of 4 quarters · filed 2019-01-18
2017-08-31$1.03M
10-Q · filed 2018-10-22
$1.64M
derived: sum of 2 quarters · filed 2018-10-22
$3.58M
derived: sum of 3 quarters · filed 2018-10-22
$5.12M
derived: sum of 4 quarters · filed 2018-10-22
2017-05-31$609.83K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-20
$2.55M
derived: sum of 2 quarters · filed 2018-09-20
$4.09M
derived: sum of 3 quarters · filed 2018-09-20
$4.71M
10-K · filed 2018-09-20
2017-02-28$1.94M
10-Q · filed 2018-04-13
$3.48M
derived: sum of 2 quarters · filed 2018-04-13
$4.10M
10-Q · filed 2018-04-13
2016-11-30$1.54M
10-Q · filed 2018-01-12
$2.16M
10-Q · filed 2018-01-12
2016-08-31$621.71K
10-Q · filed 2017-10-12